Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Eli Lilly and Co’s (LLY) second-quarter earnings, reported on Thursday, topped Wall Street estimates, supported by sound demand for its Trulicity diabetes drug.

The company also revised up its full-year adjusted earnings forecast.

Eli Lilly shares closed lower for a second consecutive trading session in New York on Thursday. It has also been the steepest single-session loss since March 20th. The stock went down 5.41% ($8.75) to $153.00, after touching an intraday low at $150.45, or a price level not seen since June 15th ($139.85).

Shares of Eli Lilly and Company have risen 16.41% so far in 2020 compared with a 0.48% gain for the benchmark index, S&P 500 (SPX).

In 2019, Eli Lilly’s stock went up 13.58%, thus, it underperformed the S&P 500, which registered a 28.88% gain.

Eli Lilly’s total revenue dropped 2.4% year-on-year to $5.50 billion during the second quarter. However, sales of the Trulicity drug rose to $1.23 billion, while exceeding a consensus of estimates of $1.21 billion.

Eli Lilly said it had taken a $250 million hit to its second-quarter sales due to a delay in patients beginning new therapies.

Meanwhile, earnings per share, which exclude special items, were reported at $1.89 during the second quarter. In comparison, analysts on average had expected adjusted earnings of $1.56 per share.

The company also revised up its full-year 2020 adjusted earnings forecast to a range of $7.20-$7.40 per share from a previously expected range of $6.70-$6.90 per share.

Analyst stock price forecast and recommendation

According to CNN Money, the 12 analysts, offering 12-month forecasts regarding Eli Lilly and Co’s stock price, have a median target of $173.00, with a high estimate of $190.00 and a low estimate of $148.00. The median estimate represents a 13.07% upside compared to the closing price of $153.00 on July 30th.

The same media also reported that at least 8 out of 15 surveyed investment analysts had rated Eli Lilly and Co’s stock as “Buy”, while 7 – as “Hold”.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Crude oil futures weekly recap, December 29 – January 2Crude oil futures weekly recap, December 29 – January 2 West Texas Intermediate and Brent crude fell on Friday, capping a sixth consecutive weekly decline, as official data showed rising supplies from Russia and Iraq at times of ever-growing US output and OPEC resisting calls to cut output, while […]
  • Binary Tribune’s Commodity Trading Signals for October 17th 2016Binary Tribune’s Commodity Trading Signals for October 17th 2016 Silver for December delivery: Buy just above $17.363, TP1 - $17.467, TP2 - $17.493, TP3 - $17.519, SL - just below $17.284.Sell just below $17.519, TP1 - $17.415, TP2 – $17.389, TP3 - $17.363, SL - just above $17.598.If break and […]
  • Royal Bank of Scotland share price up, faces fines over IT breakdownRoyal Bank of Scotland share price up, faces fines over IT breakdown Royal Bank of Scotland Group PLC, 81% owned by the British government, is faced with a fine worth tens of millions of pounds for a big IT breakdown that left customers without access to their banking accounts.RBS could be fined with as […]
  • Commodities trading outlook: gold, silver and copper futuresCommodities trading outlook: gold, silver and copper futures Gold and silver prices soared during midday trade in Europe today, as tensions over the crisis in Ukraine outweighed a strengthening dollar. Meanwhile, copper futures were lower, as traders priced in the rising dollar and concerning China […]
  • Forex Market: EUR/NZD trading forecast for MondayForex Market: EUR/NZD trading forecast for Monday During Friday’s trading session EUR/NZD traded within the range of 1.5608-1.5690 and closed at 1.5627, adding 0.19% for the day, but losing 2.61% for the week.Fundamental viewThe final annualized reading of the harmonized index of […]
  • USD/JPY advanced after Japanese GDP and Olympics winning bidUSD/JPY advanced after Japanese GDP and Olympics winning bid US dollar gained ground against the Japanese yen on Monday, following the upbeat GDP report out of Japan, while Tokyo’s winning bid to host the Olympics in 2020 bolstered optimism in Japanese Prime Minister Shinzo Abe’s fiscal and monetary […]